Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer

PURPOSE: The 21-gene recurrence score (RS) breast cancer assay is clinically used to quantify risk of 10-year distant recurrence by category (low, < 18; intermediate, 18 to 30; high, ≥ 31) for treatment management among women diagnosed with hormone receptor–positive, human epidermal growth factor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Holowatyj, Andreana N., Cote, Michele L., Ruterbusch, Julie J., Ghanem, Kristina, Schwartz, Ann G., Vigneau, Fawn D., Gorski, David H., Purrington, Kristen S.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2018
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6366808/
https://ncbi.nlm.nih.gov/pubmed/29341832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.5448
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars